Le Bonheur is a place of discovery. 

From tackling a widespread infant respiratory disease to finding better drugs to stop seizures, investigators at Le Bonheur Children's are leaving their mark on pediatric medicine.  

Le Bonheur is home to the Children's Foundation Research Center, a combined effort between Le Bonheur, the University of Tennessee Health Science Center and the Children's Foundation of Memphis.

Here, 28 full-time investigators and more than 75 post-doctoral fellows, research technicians, research nurses and study coordinators work to translate clinical expertise into laboratory discoveries that save lives and advance science.

The CFRC is also home to the Mussette and Allen Morgan Jr. Foundation for the Study of Primary Sclerosing Cholangitis - a foundation working toward the discovery of new treatments for this rare-liver disease.

In addition, Le Bonheur is set to become a national leader in studying the effects of environmental toxins on children, with the help of Environmental Epidemiologist-Toxicologist Bryan Williams, PhD.  Williams is forging a partnership between Le Bonheur and the Centers for Disease Control to learn more about how exposure to toxins through air, water, land and housing materials affect children.

Le Bonheur's Neuroscience Institute is leading national efforts to advance research in pediatric neurology.  Investigators are researching epilepsy medications and the genetic causes of epilepsy as well as hypertension in several National Institutes of Health funded studies.

Le Bonheur is also a partner in pediatric clinical pharmacology programs with the University of Tennessee and St. Jude Children's Research Hospital.  The programs are designed to improve drug therapy regimens in children by better understanding the physiologic and molecular bases underlying the relation between a drug's disposition and its effect.